104 related articles for article (PubMed ID: 2544289)
41. Open-labeled long-term study of the efficacy, safety, and tolerability of subcutaneous sumatriptan in acute migraine treatment.
Göbel H; Heinze A; Stolze H; Heinze-Kuhn K; Lindner V
Cephalalgia; 1999 Sep; 19(7):676-83; discussion 626. PubMed ID: 10524662
[TBL] [Abstract][Full Text] [Related]
42. Effect of subcutaneous sumatriptan on head temperature in migraines.
Parrinello G; Paterna S; Di Pasquale P; Pinto A; Cardinale A; Maniscalchi T; Cottone C; Follone G; Tuttolomondo A; Bologna P; Colomba D; D'Angelo A; Ortoleva A; Garofalo L; Piovana G; Capodieci E; Bova A; Giubilato A; Licata G
Drugs Exp Clin Res; 1998; 24(4):197-205. PubMed ID: 10051966
[TBL] [Abstract][Full Text] [Related]
43. An open study of self-administration of subcutaneous sumatriptan to treat successive attacks of acute migraine. Portuguese Sumatriptan Auto-injector Study Group.
J Int Med Res; 1994; 22(4):225-35. PubMed ID: 7958382
[TBL] [Abstract][Full Text] [Related]
44. The hospital management of severe migrainous headache.
Jauslin P; Goadsby PJ; Lance JW
Headache; 1991 Nov; 31(10):658-60. PubMed ID: 1663091
[TBL] [Abstract][Full Text] [Related]
45. Treatment of menstruation-associated migraine headache with subcutaneous sumatriptan.
Solbach MP; Waymer RS
Obstet Gynecol; 1993 Nov; 82(5):769-72. PubMed ID: 8414324
[TBL] [Abstract][Full Text] [Related]
46. Safety trial with the 5HT1B/1D agonist avitriptan (BMS-180048) in patients with migraine who have experienced pressure, tightness, and/or pain in the chest, neck, and/or throat following sumatriptan.
Dahlöf CG; Falk L; Risenfors M; Lewis CP
Cephalalgia; 1998 Oct; 18(8):546-51. PubMed ID: 9827246
[TBL] [Abstract][Full Text] [Related]
47. Twelve-month tolerability and efficacy study of NP101, the sumatriptan iontophoretic transdermal system.
Smith TR; Goldstein J; Singer R; Pugach N; Silberstein S; Pierce MW
Headache; 2012 Apr; 52(4):612-24. PubMed ID: 22352764
[TBL] [Abstract][Full Text] [Related]
48. A randomized double-blind placebo-controlled crossover study of subcutaneous sumatriptan in general practice.
Russell MB; Holm-Thomsen OE; Rishøj Nielsen M; Cleal A; Pilgrim AJ; Olesen J
Cephalalgia; 1994 Aug; 14(4):291-6. PubMed ID: 7954759
[TBL] [Abstract][Full Text] [Related]
49. Subcutaneous sumatriptan provides symptomatic relief at any pain intensity or time during the migraine attack.
Linde M; Mellberg A; Dahlöf C
Cephalalgia; 2006 Feb; 26(2):113-21. PubMed ID: 16426264
[TBL] [Abstract][Full Text] [Related]
50. Sumatriptan for the treatment of acute migraine headache.
Long K; Long R
Nurse Pract Forum; 1993 Sep; 4(3):124-5. PubMed ID: 8396482
[No Abstract] [Full Text] [Related]
51. Therapeutic applications for subcutaneous triptans in the acute treatment of migraine.
Erlichson K; Waight J
Curr Med Res Opin; 2012 Jul; 28(7):1231-8. PubMed ID: 22401601
[TBL] [Abstract][Full Text] [Related]
52. Pharmacology and efficacy of eletriptan for the treatment of migraine attacks.
Diener HC; McHarg A
Int J Clin Pract; 2000 Dec; 54(10):670-4. PubMed ID: 11221281
[TBL] [Abstract][Full Text] [Related]
53. Zelrix: a novel transdermal formulation of sumatriptan.
Pierce M; Marbury T; O'Neill C; Siegel S; Du W; Sebree T
Headache; 2009 Jun; 49(6):817-25. PubMed ID: 19438727
[TBL] [Abstract][Full Text] [Related]
54. Sumatriptan in chronic cluster headache: results of continuous treatment for eleven months.
Ekbom K; Waldenlind E; Cole J; Pilgrim A; Kirkham A
Cephalalgia; 1992 Aug; 12(4):254-6. PubMed ID: 1326405
[TBL] [Abstract][Full Text] [Related]
55. Valdecoxib for treatment of a single, acute, moderate to severe migraine headache.
Kudrow D; Thomas HM; Ruoff G; Ishkanian G; Sands G; Le VH; Brown MT
Headache; 2005 Oct; 45(9):1151-62. PubMed ID: 16178945
[TBL] [Abstract][Full Text] [Related]
56. Transdermal sumatriptan for acute treatment of migraineurs with baseline nausea.
Schulman EA
Headache; 2012 Feb; 52(2):204-12. PubMed ID: 22229837
[TBL] [Abstract][Full Text] [Related]
57. Eletriptan for the treatment of migraine in patients with previous poor response or tolerance to oral sumatriptan.
Färkkilä M; Olesen J; Dahlöf C; Stovner LJ; ter Bruggen JP; Rasmussen S; Muirhead N; Sikes C
Cephalalgia; 2003 Jul; 23(6):463-71. PubMed ID: 12807526
[TBL] [Abstract][Full Text] [Related]
58. Satisfaction with and confidence in needle-free subcutaneous sumatriptan in patients currently treated with triptans.
Cady RK; Aurora SK; Brandes JL; Rothrock JF; Myers JA; Fox AW; Farr SJ
Headache; 2011 Sep; 51(8):1202-11. PubMed ID: 21812775
[TBL] [Abstract][Full Text] [Related]
59. Subcutaneous sumatriptan in the treatment of acute episodes of posttraumatic headache.
Gawel MJ; Rothbart P; Jacobs H
Headache; 1993 Feb; 33(2):96-7. PubMed ID: 8384612
[TBL] [Abstract][Full Text] [Related]
60. Effect of subcutaneous sumatriptan, a selective 5HT1 agonist, on the systemic, pulmonary, and coronary circulation.
MacIntyre PD; Bhargava B; Hogg KJ; Gemmill JD; Hillis WS
Circulation; 1993 Feb; 87(2):401-5. PubMed ID: 8381056
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
